Box 22 Herpes Zoster – The Same Virus, a Different Disease

In 10–20% of children infected with varicella, the virus takes up residence in nerve cells, where it lies dormant for several decades, until a lowering of the host’s immune defences (as a result of ageing, disease, or immunosuppressive treatment) allows it to awaken, begin replicating, and precipitate herpes zoster disease, or shingles as it is commonly known . In the United States alone, 43 million people are believed to be at risk of herpes zoster. 



Herpes zoster is characterized by a painful blistering rash along the distribution of the infected nerve cells. In many elderly people the rash and pain subside and resolve completely in a few weeks. In about 15% of patients, though, pain and numbness in the area of the rash can last for weeks or months. The pain can be severe and highly disabling, both physically and mentally. Itching, which may fluctuate from mild to intense, adds to the person’s discomfort. In addition, 8–15% of people suffer permanent neurological damage, impaired vision, or problems of bowel or bladder function. Elderly people and immune-compromised people run the highest risk of developing herpes zoster. Since the same virus causes varicella, people with herpes zoster constitute a source of varicella outbreaks among unvaccinated children and other non-immune population groups. 



Treatment with antiviral drugs is effective if started soon after the onset of herpes zoster. However, accurate diagnosis at that stage of the infection is difficult and in most cases antiviral treatment is begun too late to be of optimal benefit . In 2005, a vaccine against herpes zoster was licensed for use in people over 60 years of age. 



It contains at least 14 times the amount of virus as the varicella vaccine. Its protective efficacy, though, varies with the recipient’s age, falling from 64% in the 60–69 year age group to 41% in the 70–79 year age group, and 18% in the 80–89 year age group. Some herpes zoster experts believe younger age groups – such as people in their 50s, who account for almost 20% of herpes zoster cases – could benefit from the vaccine. 



Two factors, though, militate against its widespread adoption by developing countries: price (the vaccine currently costs about US$ 150 a dose in industrialized countries), and the low public health priority of herpes zoster in relation to the many other serious diseases that ravage these countries.

Get the update at the webpage

Comments

Post a Comment

Popular posts from this blog

Vaccines for Adolescents: A new generation of vaccines

Image
Teenagers, similar to grown-ups, were prescribed to get lockjaw supporters at regular intervals; most requiring their first promoter portion around age 11. Other than this, nonetheless, most youths did not require extra vaccines except if they missed one in adolescence. By 2005, vaccines explicitly prescribed for teenagers were suggested for sub-bunches dependent on where they lived or restorative conditions that they had. In any case, another gathering of immunizations ended up accessible in the last piece of the decade. Vaccines for meningococcus and human papillomavirus (HPV) and in addition extended suggestions for flu and pertussis presently give chances to young people to be secured as they enter their high school years. 2000 Recommended Vaccines Td Catch-up MMR Hepatitis B Varicella Sub-groups Hepatitis A 2005 Recommended Vaccines Td Catch-up MMR Hepatitis B Varicella Sub-groups Hepatitis A Pneumococcus Influenza 2010 Recommended Vaccines Tdap HPV Men
Read more

Do Vaccines Cause Autism

Image
Regardless of whether the high rates of a mental imbalance today are because of expanded determination and detailing, changing meanings of extreme introvertedness or a real increment in the advancement of ASD is obscure.  In any case, scientists and stressed guardians alike have conjectured over the reasons for a mental imbalance, and the issue has been generally contemplated. The job of immunizations has been addressed, alongside other conceivable hazard factors for ASD, for example, hereditary inclination, progressed parental age, and other natural elements. Antibodies have maybe gotten more examination than some other hypothesized the reason for ASD, and the immense larger part of researchers, doctors, and general wellbeing analysts have reached the end that there is no relationship among immunizations and a mental imbalance. A few, nonetheless, still inquiry whether immunizations assume a job in ASD advancement, thus the general wellbeing and therapeutic foundations keep
Read more

VAR2CSA DBL1-2 : A Lead Antigen for Malaria Vaccine Development

Image
Jungle fever caused by Plasmodium constitutes a noteworthy medical issue is as yet a standout amongst the most widely recognized dangerous irresistible maladies on the planet. In 2016, the worldwide count of jungle fever achieved 216 million cases and 445,000 passing, a substantially larger part of them coming about because of Plasmodium falciparum infection.1 Individuals living in high P. falciparum transmission settings step by step obtain insusceptibility to the most serious clinical signs of the contamination. Every year, PM is in charge of 20% of stillbirths in sub-Saharan Africa, 11% of every infant passing in sub-Saharan Africa, and 10,000 maternal passing all around. Over 50 million women are exposed to the risk of malaria during pregnancy every year. Malaria during pregnancy is a leading global cause of maternal morbidity and adverse pregnancy outcomes. Adhesion of infected erythrocytes to placental chondroitin-4-sulfate (CSA) has been linked to the outcome of pla
Read more